Jefferies Maintains Bullish View on Synta Pharma. (SNTA) on GALAXY Survival Data
Tweet Send to a Friend
Jefferies reiterated their Buy rating and $14 price target on Synta Pharma. (NASDAQ: SNTA) after calculating and interpreting the GALAXY ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
